Cardiology
Heart drug improves exercise tolerance in clinical trial of patients with hypertrophic obstructive cardiomyopathy
Exercise intolerance is often severe among patients with cardiovascular disease and can impose significant limitations on their physical abilities and quality of life. Medications known as cardiac myosin inhibitors (CMIs) ...
Sep 4, 2024
0
0